开盘$22.33
昨收$22.82
当日区间$22.32 – $22.73
成交量6.83M
市值$74.23B
市盈率（TTM）8.3
股息率2.72%
BCS 相关新闻
匹配 Barclays 或代码 BCS 的头条新闻，按最新排序。
- Former Barclays CEO: The Clarity Act is really good for banks, and the largest and most successful banks will benefit from it.
- RBC Trims Price Target on Barclays to GBP5.50 From GBP5.75, Keeps Outperform Rating 正面
- Correct: Barclays Group 2Q Net Interest Income GBP3.92B
- U.S. Stocks Move | Barclays falls 5.6% in pre-market trading despite a 31% year-over-year increase in Q2 profit, as costs and impairments surge 正面
- OTS Holdings: General Announcement-Proposed acquisition by BCS Development Pte. Ltd.
- Barclays: U.S. 30-Year Treasury Yield Could Rise to 6% if Productivity Growth Continues to Accelerate 正面
- Barclays PLC increased its stake in Dongjiang Environmental by 12.7888 million shares at approximately HK$1.93 per share.
- Barclays (BCS.US) has appointed Ramin Naji as Head of Healthcare and Real Estate for the Asia-Pacific region.
- Morgan Stanley reportedly poaches a key executive from Barclays to serve as Vice Chairman of its Technology Investment Banking division.
- Barclays Maintains International Flavors & Fragrances(IFF.US) With Buy Rating, Cuts Target Price to $103 负面
- Barclays Maintains Cardinal Health(CAH.US) With Buy Rating, Maintains Target Price $275
- Barclays Maintains ICG PLC(ICGUF.US) With Buy Rating, Cuts Target Price to $35.46 负面
- Barclays Maintains Nova(NVMI.US) With Buy Rating, Cuts Target Price to $500 负面
- Barclays Maintains SiTime(SITM.US) With Buy Rating, Maintains Target Price $850
- Barclays Maintains AUMOVIO SE(AMVIF.US) With Buy Rating, Cuts Target Price to $66.9 负面
暂无评论——快来第一个聊聊 BCS。
登录后参与讨论。